Example table 13: Overview of adverse events Study [insert study reference or identifier] Study [insert study reference or identifier] Study [insert study reference or identifier] Intervention Comparator Relative Risk Intervention Comparator Relative Risk Intervention Comparator Relative Risk (n = x) risk (95% difference (n = x) (n = x) risk (95% difference (n = x) risk (95% difference (n = x) (n = x) CI) (95% CI) CI) (95% CI) CI) (95% CI) n (%) n (%) n (%) n (%) n (%) n (%) Total number of adverse events Total number of serious adverse events Total number of deaths Total number of adverse events leading to temporary or permanent treatment withdrawal Total number of withdrawals from the study because of adverse events Adapted from European Public Assessment Reports published by the European Medicines Agency From tables 3a and 5 of the EUnetHTA safety guideline
Example table 13: Overview of adverse events Study [insert study reference or identifier] Study [insert study reference or identifier] Study [insert study reference or identifier] Intervention (n = x) n (%) Comparator (n = x) n (%) Relative risk (95% CI) Risk difference (95% CI) Intervention (n = x) n (%) Comparator (n = x) n (%) Relative risk (95% CI) Risk difference (95% CI) Intervention (n = x) n (%) Comparator (n = x) n (%) Relative risk (95% CI) Risk difference (95% CI) Total number of adverse events Total number of serious adverse events Total number of deaths Total number of adverse events leading to temporary or permanent treatment withdrawal Total number of withdrawals from the study because of adverse events Adapted from European Public Assessment Reports published by the European Medicines Agency From tables 3a and 5 of the EUnetHTA safety guideline